Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Qiagen's QIAxpert and Cancer Workbench; Lexogen's RNA-seq Library Prep Kits

Premium

Qiagen has launched QIAxpert for quantification and quality control of DNA and RNA samples for next-generation sequencing. QIAxpert is a UV/VIS spectrophotometer that enables laboratories to effortlessly assess the quality and quantity of nucleic acids in up to 16 samples within just two minutes, according to the company.

Qiagen has also launched the CLC Cancer Research Workbench, a bioinformatics solution for interpretation of next-gen sequencing data for cancer research.


Lexogen has launched QuantSeq 3' mRNA-seq Library Prep, which generates Illumina-compatible libraries of the sequences close to the 3' end of polyadenylated RNA. The kit produces one fragment per transcript in order to give accurate gene expression values.

It has also launched the AutoSense mRNA-seq Library Prep kit, an automated version of its SENSE mRNA-seq kit. It is also compatible with Illumina sequencing as well as automation on PerkinElmer's Sciclone and Zephyr systems.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.